Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 19

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 19
---
 pre-funded warrants to purchase up to 40,894 shares of common stock at an exercise price of $0.001 per share at a price to the public of $4.399 per pre-funded warrant, for aggregate gross proceeds of approximately $3,000, before deducting underwriting discounts and commissions and other estimated offering expenses of $130 resulting in net proceeds of $2,870. The offering was closed on September 5, 2025. Warrants A summary of activity of the warrants during the nine months ended September 30, 2025, is as follows:         Weighted    Number of   Weighted Average   Average    Shares  Exercise Price  Life (years) Outstanding, December 31, 2024  23,315  $67.50   0.79 Granted  824,143   6.04   5.00 Expired  -   -   - Exercised  (101,372)  1.30   - Outstanding, September 30, 2025  746,086  $8.60   4.59  The intrinsic value of the warrants as of September 30, 2025, is $254. All of the outstanding warrants are exercisable as of September 30, 2025. 2018 Equity Incentive Plan On February 28, 2025, the number of shares available under the Company’s 2018 Equity Incentive Plan, as amended (the “2018 Plan”), was increased by 80,693 shares of common stock. As of September 30, 2025, the 2018 Plan permits the Company to issue up to an aggregate of 335,564 shares of common stock of which 107,722 shares are available to be issued. The following is a summary of stock option activity during the nine months ended September 30, 2025:   Options Outstanding  Weighted Average   Number of  Weighted Average  Remaining Life    Options  Exercise Price  (years) Outstanding, December 31, 2024  128,976  $11.03   7.76 Granted  98,866   11.03   10.00 Exercised  -   -   -